675 related articles for article (PubMed ID: 20624441)
1. Mitochondrial dysfunction and Alzheimer's disease.
Maruszak A; Żekanowski C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease.
Tanaka N; Goto Y; Akanuma J; Kato M; Kinoshita T; Yamashita F; Tanaka M; Asada T
Mitochondrion; 2010 Jan; 10(1):32-7. PubMed ID: 19703591
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
5. Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.
Oliver DMA; Reddy PH
J Alzheimers Dis; 2019; 72(s1):S95-S116. PubMed ID: 30932888
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?
Mancuso M; Orsucci D; Siciliano G; Murri L
Curr Alzheimer Res; 2008 Oct; 5(5):457-68. PubMed ID: 18855587
[TBL] [Abstract][Full Text] [Related]
9. Role of mitochondrial dysfunction in Alzheimer's disease.
Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
11. Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction. Hypothetical role of the adapter protein ECSIT in familial and sporadic Alzheimer's disease pathogenesis.
Soler-López M; Badiola N; Zanzoni A; Aloy P
Bioessays; 2012 Jul; 34(7):532-41. PubMed ID: 22513506
[TBL] [Abstract][Full Text] [Related]
12. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA.
Mancuso M; Orsucci D; LoGerfo A; Calsolaro V; Siciliano G
Adv Exp Med Biol; 2010; 685():34-44. PubMed ID: 20687493
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.
Cardoso SM; Pereira CF; Moreira PI; Arduino DM; Esteves AR; Oliveira CR
Exp Neurol; 2010 Jun; 223(2):294-8. PubMed ID: 19559703
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
[TBL] [Abstract][Full Text] [Related]
16. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease.
Querfurth HW; LaFerla FM
N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
[No Abstract] [Full Text] [Related]
18. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain.
Raukas M; Rebane R; Mahlapuu R; Jefremov V; Zilmer K; Karelson E; Bogdanovic N; Zilmer M
Free Radic Res; 2012 Dec; 46(12):1490-5. PubMed ID: 22962855
[TBL] [Abstract][Full Text] [Related]
19. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
Huang Y
Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
[TBL] [Abstract][Full Text] [Related]
20. Behavioral stress causes mitochondrial dysfunction via ABAD up-regulation and aggravates plaque pathology in the brain of a mouse model of Alzheimer disease.
Seo JS; Lee KW; Kim TK; Baek IS; Im JY; Han PL
Free Radic Biol Med; 2011 Jun; 50(11):1526-35. PubMed ID: 21382475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
